NasdaqGS - Delayed Quote USD
Nanobiotix S.A. (NBTX)
3.3410
-0.1390
(-3.99%)
At close: May 2 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | -0.69 | -0.04 |
| Low Estimate | 0 | 0 | -0.92 | -0.62 |
| High Estimate | 0 | 0 | -0.52 | 0.74 |
| Year Ago EPS | -- | -- | -1.44 | -0.69 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 7 | 7 |
| Avg. Estimate | -- | -- | 18.95M | 51.11M |
| Low Estimate | -- | -- | 4.42M | 4.42M |
| High Estimate | -- | -- | 42.6M | 101.2M |
| Year Ago Sales | -- | -- | -7.19M | 18.95M |
| Sales Growth (year/est) | -- | -- | 363.51% | 169.71% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.69 | -0.04 |
| 7 Days Ago | 0 | 0 | -0.91 | -0.08 |
| 30 Days Ago | 0 | 0 | -0.94 | -0.83 |
| 60 Days Ago | 0 | 0 | -0.95 | -1.03 |
| 90 Days Ago | 0 | 0 | -0.95 | -1.03 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NBTX | -- | -- | 51.91% | 93.73% |
| S&P 500 | 12.40% | 3.81% | 8.28% | 13.79% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/4/2025 |
| Initiated | Guggenheim: Buy | 8/28/2024 |
| Initiated | Leerink Partners: Outperform | 12/8/2023 |
| Initiated | Evercore ISI Group: Outperform | 1/6/2021 |
Related Tickers
IPHA Innate Pharma S.A.
2.2600
+0.89%
2Q5.F Renovaro Inc.
0.2340
-8.24%
AKBLF ALK-Abelló A/S
19.90
0.00%
LVTX LAVA Therapeutics N.V.
1.2800
+3.23%
BXRXQ Baudax Bio, Inc.
0.0000
0.00%
RVLPQ RVL Pharmaceuticals plc
0.0000
0.00%
MCET MultiCell Technologies, Inc.
0.0000
0.00%
EMMA Emmaus Life Sciences, Inc.
0.0165
0.00%
GNFT Genfit S.A.
4.2780
+4.60%
ATH.AX Alterity Therapeutics Limited
0.0090
0.00%